Skip to main navigation Skip to search Skip to main content

Comparative bioavailability of different formulations of MK-679 an orally active LTD4 receptor antagonist

  • L. Yogendran
  • , K. McLaughlin
  • , E. B. Vadas
  • , D. J. Margolskee
  • , S. Bechard
  • , J. Y.K. Hseih
  • , C. Lin
  • , J. D. Rogers
  • , D. G. Sciberras
  • , I. M. James

Research output: Contribution to journal › Article › peer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)169P-170P
JournalBritish Journal of Clinical Pharmacology
Volume34
Issue number2
StatePublished - 1992
Externally publishedYes

Cite this